FR2351954A1 - Nouveaux polypeptides et composition pharmaceutique les contenant - Google Patents

Nouveaux polypeptides et composition pharmaceutique les contenant

Info

Publication number
FR2351954A1
FR2351954A1 FR7708538A FR7708538A FR2351954A1 FR 2351954 A1 FR2351954 A1 FR 2351954A1 FR 7708538 A FR7708538 A FR 7708538A FR 7708538 A FR7708538 A FR 7708538A FR 2351954 A1 FR2351954 A1 FR 2351954A1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition containing
new polypeptides
polypeptides
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7708538A
Other languages
English (en)
Other versions
FR2351954B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICHIGAN ETAT
Original Assignee
MICHIGAN ETAT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed by MICHIGAN ETAT filed Critical MICHIGAN ETAT
Publication of FR2351954A1 publication Critical patent/FR2351954A1/fr
Application granted granted Critical
Publication of FR2351954B1 publication Critical patent/FR2351954B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7708538A 1976-03-23 1977-03-22 Nouveaux polypeptides et composition pharmaceutique les contenant Granted FR2351954A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2351954A1 true FR2351954A1 (fr) 1977-12-16
FR2351954B1 FR2351954B1 (fr) 1980-03-28

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7708538A Granted FR2351954A1 (fr) 1976-03-23 1977-03-22 Nouveaux polypeptides et composition pharmaceutique les contenant

Country Status (13)

Country Link
JP (1) JPS52142015A (fr)
AU (1) AU510679B2 (fr)
CA (1) CA1103239A (fr)
DE (1) DE2712781A1 (fr)
DK (1) DK125177A (fr)
FR (1) FR2351954A1 (fr)
GB (1) GB1561247A (fr)
GR (1) GR63642B (fr)
LU (1) LU76998A1 (fr)
NL (1) NL7703124A (fr)
NO (1) NO771031L (fr)
NZ (1) NZ183627A (fr)
SE (1) SE7702925L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬

Also Published As

Publication number Publication date
NO771031L (no) 1977-09-26
FR2351954B1 (fr) 1980-03-28
GR63642B (en) 1979-11-27
NZ183627A (en) 1980-02-21
AU2317477A (en) 1978-09-14
AU510679B2 (en) 1980-07-10
LU76998A1 (fr) 1977-10-03
DE2712781A1 (de) 1977-10-06
NL7703124A (nl) 1977-09-27
DK125177A (da) 1977-09-24
GB1561247A (en) 1980-02-13
SE7702925L (sv) 1977-09-24
JPS52142015A (en) 1977-11-26
CA1103239A (fr) 1981-06-16

Similar Documents

Publication Publication Date Title
BE876732A (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
LU80795A1 (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE859911A (fr) Nouveaux deodorants ou desodorisants et compositions les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
BE858605A (fr) Nouveaux acides 5-alkoxymidazo (1,2-a)quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
FR2345450A1 (fr) Quinoxalinones et quinoxalines, leurs procedes de preparation et composition pharmaceutique les contenant
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
FR2283686A1 (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
BE855022A (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
BE811856A (fr) Nouveaux derives de quinazoline et composition pharmaceutique les contenant
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE815584A (fr) Nouveaux 3-alkyl-9-aminoalkyl-1,2,3,4-tetra-hydrocarbazoles et composition pharmaceutique les contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
BE856628A (fr) Nouveaux metaaminophenols et compositions tinctoriales les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant
FR2351954A1 (fr) Nouveaux polypeptides et composition pharmaceutique les contenant
BE883859A (fr) Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant
BE812145A (fr) Nouveaux carbothiolates et herbicides les contenant
FR2334369A1 (fr) Nouveaux nonapeptides et medicament les contenant
BE832121A (fr) Nouveaux composes anti-arythmiques et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse